Clinical Trial

The Warmth, Anticipation, Sensation, Aversion, and Body-part Imaging Study

Study acronym: WASABI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 14, 2026 (before its estimated February 26, 2026 completion). Its status may not reflect the trial's current state.
Summary
This functional magnetic-resonance imaging study of the brain will feature a within-subject crossover design to investigate the effects of a placebo cream on painful thermal stimulation rendered upon eight body sites. The investigators aim to 1.) improve the understanding of how the brain represents thermal pain responses somatotopically (i.e., across different body-sites) 2.) to test these brain representations with and without the presence of a pain-targeted placebo intervention, and 3.) to examine how these brain representations change prior to vs. during the delivery of thermal pain. They predict that placebo cream will downregulate the intensity of aversive brain activity representations, and to a lesser degree, sensation and somatotopic representations, both prior to and during painful thermal stimulation.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2020-11-25; most recent amendment 2026-01-12.
Status change: Not Yet Recruiting → Recruiting 2021-04-01
Trial Details
NCT Number NCT04653064
Lead Sponsor Trustees of Dartmouth College
Conditions Pain
Enrollment 150 participants
Start Date 2021-03-19
Primary Completion 2026-02-26 (estimated)
Study Completion 2026-12-26 (estimated)
Updated on ClinicalTrials.gov 2026-01-14